Tempero Bio
Developer of transformative therapies designed for treating and preventing substance use disorders. The company offers a potent, orally available metabotropic glutamate receptor (mGluR5) negative allo...
Valuation
$148M
Latest known
Share Price
N/A
Total Raised
$88.6M
Last Round
N/A